🟢 Quantum BioPharma is trading 7.54% up today after FDA approval of Lucid-MS IND

Quantum BioPharma is trading at $3.71 (+7.54%) after the FDA approved Quantum BioPharma’s IND application for Lucid-MS.

• The clearance enables the company to immediately begin Phase 2 development targeting progressive multiple sclerosis.
• The milestone is a clear company-specific catalyst, while broader markets trade largely sideways ahead of Wednesday’s CPI report.